141 related articles for article (PubMed ID: 38814482)
21. Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer.
Chung SY; Takiyama H; Kang JH; Chang JS; Min BS; Tsuji H; Yamada S; Koom WS
Sci Rep; 2022 Feb; 12(1):1845. PubMed ID: 35115612
[TBL] [Abstract][Full Text] [Related]
22. Comparison of carbon ion and photon reirradiation for recurrent glioblastoma.
Lautenschlaeger FS; Dumke R; Schymalla M; Hauswald H; Carl B; Stein M; Keber U; Jensen A; Engenhart-Cabillic R; Eberle F
Strahlenther Onkol; 2022 May; 198(5):427-435. PubMed ID: 34523017
[TBL] [Abstract][Full Text] [Related]
23. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
24. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
25. Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies.
Yang J; Gao J; Hu J; Hu W; Qiu X; Huang Q; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1200. PubMed ID: 36544688
[TBL] [Abstract][Full Text] [Related]
26.
Fang X; Sun P; Dong Y; Huang Y; Lu JJ; Kong L
Front Oncol; 2023; 13():896142. PubMed ID: 37081974
[TBL] [Abstract][Full Text] [Related]
27. Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
Radiother Oncol; 2023 Jun; 183():109640. PubMed ID: 36990390
[TBL] [Abstract][Full Text] [Related]
28. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract][Full Text] [Related]
29. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
Singh AK; Lockett MA; Bradley JD
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
Fukuhara M; Urabe Y; Oka S; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayashi R; Nishibuchi I; Murakami Y; Nagata Y; Tanaka S
Esophagus; 2023 Jul; 20(3):541-547. PubMed ID: 37027046
[TBL] [Abstract][Full Text] [Related]
31. Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG).
Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shimizu K; Shioyama Y
J Thorac Oncol; 2024 Mar; 19(3):491-499. PubMed ID: 37924974
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.
Ishikawa Y; Suzuki M; Yamaguchi H; Seto I; Machida M; Takagawa Y; Jingu K; Kikuchi Y; Murakami M
J Med Case Rep; 2022 Feb; 16(1):68. PubMed ID: 35152904
[TBL] [Abstract][Full Text] [Related]
33. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
34. Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial.
Pöttgen C; Gkika E; Stahl M; Abu Jawad J; Gauler T; Kasper S; Trarbach T; Herrmann K; Lehmann N; Jöckel KH; Lax H; Stuschke M
Radiat Oncol; 2021 Mar; 16(1):59. PubMed ID: 33757534
[TBL] [Abstract][Full Text] [Related]
35. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958
[TBL] [Abstract][Full Text] [Related]
36. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study.
Makishima H; Yasuda S; Isozaki Y; Kasuya G; Okada N; Miyazaki M; Mohamad O; Matsufuji N; Yamada S; Tsuji H; Kamada T;
Cancer Sci; 2019 Jan; 110(1):303-309. PubMed ID: 30417485
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: a single institute experience.
Sasaki T; Nakamura K; Shioyama Y; Toh Y; Okamura K; Ohura H; Hirata H; Honda H
Am J Clin Oncol; 2007 Oct; 30(5):514-9. PubMed ID: 17921713
[TBL] [Abstract][Full Text] [Related]
38. Definitive carbon ion radiotherapy for tracheobronchial adenoid cystic carcinoma: a preliminary report.
Chen J; Mao J; Ma N; Wu KL; Lu J; Jiang GL
BMC Cancer; 2021 Jun; 21(1):734. PubMed ID: 34174854
[TBL] [Abstract][Full Text] [Related]
39. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
[TBL] [Abstract][Full Text] [Related]
40. Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
Deng W; Yang J; Ni W; Li C; Chang X; Han W; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Deng L; Wang W; Bi N; Zhang T; Li Y; Gao S; Xue Q; Mao Y; Sun K; Liu X; Fang D; Wang D; Li J; Zhao J; Shao K; Li Z; Chen X; Han L; Wang L; He J; Xiao Z
Oncologist; 2020 Apr; 25(4):e701-e708. PubMed ID: 32083766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]